LSL Pharma Group Inc (TSE:LSL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
LSL Pharma Group Inc. reported impressive financial results for Q3-24, with revenues up 60% and a significant reduction in net losses by 84% compared to the previous year. The company also raised $2.4 million through debt financings to bolster its growth initiatives, including doubling production capacity at Steri-Med Pharma.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.
